Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Rui Wan being referenced
Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity
2023
Abstract CT513: Phase I study of IBI322 (anti-CD47/PD-L1 bispecific antibody) monotherapy therapy in patients with advanced solid tumors in China
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Rui Wan | 387 | 243 | 227 | 71 | 802 | |
| Yujie Zhao | 339 | 404 | 361 | 64 | 967 | |
| Yan Zhang | 251 | 223 | 322 | 81 | 863 | |
| Zhenxiang Li | 469 | 271 | 311 | 65 | 906 | |
| Desheng Hu | 264 | 175 | 247 | 65 | 803 | |
| Linlin Yang | 423 | 164 | 320 | 76 | 914 | |
| Songbing Qin | 415 | 204 | 176 | 47 | 735 | |
| Xia Yang | 361 | 223 | 154 | 46 | 884 | |
| Yang Liu | 295 | 123 | 241 | 43 | 689 | |
| Yonina R. Murciano‐Goroff | 560 | 260 | 266 | 47 | 952 | |
| Xiang Hu | 465 | 298 | 227 | 61 | 951 |
All Works
Login with ORCID to disown or claim papers
Loading papers...